July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  

DoD FY25 Peer Reviewed Cancer Career Development Award – Fellow and Resident Option
Jun 30, 2025, 13:02

DoD FY25 Peer Reviewed Cancer Career Development Award – Fellow and Resident Option

Supports early-career cancer researchers—either post-terminal-degree Fellows (within 7 years of degree) or Clinician-Scientists in Residency—by funding mentored projects that address a critical problem in one of the FY25 PRCRP topic areas and strategic goals, fostering career development alongside impactful research.

Eligibility Criteria:

  • Fellow Option:

    • Early-career researcher or physician-scientist at or above Research Assistant Professor/Instructor level.

    • Within 7 years of terminal degree by July 3, 2025 (excluding clinical training or family leave).

    • Postdoctoral fellows not eligible as PIs; nominal prior career-development funding only.

    • Must designate a Career Guide at Associate Professor level or higher with a strong cancer research record.

  • Resident Option:

    • Resident in an accredited graduate medical education program with institutional support for lab space and protected research time.

    • Two levels of effort:

      • Level 1: One-year project (total cost cap $280,000).

      • Level 2: Two-year project (total cost cap $560,000).

    • Postdoctoral fellows not eligible; must also designate a Career Guide as above.

  • General: Applicants and Career Guides may be at different institutions; no citizenship restrictions; cost sharing not required.

Funding Details:

  • Total Pool: Approximately $6.72 M to fund ~12 awards 

  • Cost Caps (Total Costs = direct + indirect):

    • Fellow Option: $560,000 over up to 3 years

    • Resident Option Level 1: $280,000 over 1 year

    • Resident Option Level 2: $560,000 over 2 years

  • Period of Performance: Awards made by September 30, 2026; funds expire September 30, 2031

  • Allowable Costs: Salary support, supplies, equipment, travel (multi-institutional collaboration + one scientific meeting per year); no clinical trial costs.

Deadlines:

  • Letter of Intent (pre-application): June 20, 2025 by 5 p.m. ET

  • Full Application: July 3, 2025 by 11:59 p.m. ET

  • End of Verification Period: July 8, 2025 by 5 p.m. ET

  • Peer Review: September 2025

  • Programmatic Review: November 2025 

Where to Go for Further Information & Application: